REGEN-COV antibody therapy cuts severe COVID risk at half dose, late-stage trial results show … Drug improves memory and function for those with dementia and ‘silent seizures’ … Depression relapse risk higher when long-term antidepressant therapy is stopped, study finds … FDA’s vaccine leader says COVID ‘boosters’ may really just be a 3rd shot in the primary series
Clinical briefs for Friday, Oct 1
![](https://www.mcknights.com/wp-content/uploads/sites/5/2021/10/GettyImages-1211231354-860x484.jpg)
October 1, 2021